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ABSTRACT 
Effects of Testosterone on Female Rat Sexual Behavior 
Sherri Lee Jones 
Estrogen and progesterone are ovarian steroid hormones involved in the initiation 
and maintenance of female sexual behaviors. Recent research suggests that testosterone 
(T) is also important in sexual behavior, particularly in the restoration of libido in 
surgically and naturally menopausal women when administered with estrogen (E). The 
effect of T on the female sexual behavior of aged intact, and young ovariectomized rats 
has been poorly described in the current literature, despite varying reports of facilitative 
and inhibitory effects. The goal of the present thesis was to examine the actions of E, T, 
or their combination, in the restoration of sexual activity at a time when ovarian function 
is altered either through aging or surgical removal of the ovaries. The effects of both 
acute and chronic administration of these hormones on sexual behavior were observed. 
The results of these experiments suggest that the combined action of E with T may 
facilitate sexual behaviors in young ovariectomized female rats, to levels equivalent to 
optimal priming with E and progesterone. When varying hormone regimens were 
administered to aged intact animals, by phasic subcutaneous injections every four days, 
there was no effect on their sexual behavior acutely, whereas chronic T and E+T resulted 
in an attenuation of sexual behaviors. When a continuous release of T was administered 
to aged intact female rat by subcutaneous capsule, sexual behaviors were initially 
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Introduction 
Sex steroid hormones have traditionally been categorized as either male or 
female, where androgens are considered male sex steroids since they have 
masculinization effects, and estrogens as female sex steroids because of their importance 
in the estrous cycle. Testosterone is an androgen viewed as a male steroid hormone 
however both the adrenals and ovaries produce it in females (Belanger, Cusan, Caron, 
Barden, & Dupont, 1981; Hall, Leathard, & Coley, 2001). Testosterone (T) is a precursor 
to both estradiol (E2) and the androgen dihydrotestosterone (DHT). Testosterone can 
bind to the androgen receptor either directly, or through its reduction to DHT, and its 
aromatization to E2 allows binding to^strogen receptors (ERa or ER|3). Steroid hormone 
binding globulins (SHBG) are proteins that bind steroid hormones and render them 
inactive, and these proteins have a higher affinity for androgens such as T than they do 
for E2 (Bachmann et al., 2002). 
In recent years, the role of T in female sexual desire stimulated much interest, 
particularly with respect to menopausal women. As women enter menopause the ovaries, 
which produce estrogens (E), progesterone (P) and androgens such as T, begin to decline 
in their functioning. This reduction in functioning leads to diminished E and P levels. In 
contrast, T declines between the ages of 21 and 40 but remains relatively stable 
throughout the menopausal transition (Burger, 2008). 
Menopause can be surgically induced by the removal of the ovaries and/or uterus, 
as a treatment for hormone-related cancers or heavy bleeding during menses that can 
trigger hemorrhages. These women experience an abrupt decline in E, P as well as T 
(Alexander, Dennerstein, Burger, & Graziottin, 2006; Henderson & Sherwin, 2007; 
1 
Kingsberg, 2007; Nathorst-Boos, von Schoulttz, & Carlstrom, 1993). An American based 
study, WISHeS, found that 9% of naturally postmenopausal women and 26% of 
surgically menopausal women experience low desire (Alexander et al., 2006; Leiblum et 
al., 2006). 
In both naturally and surgically menopausal women reductions in E and P lead to 
numerous physiological disruptions and impairments such as fluctuations in mood, loss 
of skin elasticity, decreased bone density, vaginal dryness, thinning of the vaginal wall as 
well as psychological deficits such as impaired memory and loss of sexual desire 
(Dennerstein, Guthrie, Hayes, DeRogatis, & Lehert, 2008; Sherwin, 1994; 1996). The 
majority of these symptoms can be alleviated with estrogen replacement therapy (ERT) 
and as such, their occurrence has been attributed to the decline in ovarian E2 production. 
Unfortunately, the loss of sexual desire experienced following menopause, is not 
restored with E alone, or with a regimen of E and P (Sherwin, 1991; 2008). Moreover, the 
addition of P to ERT can have a negative impact on mood including increased distress, 
depression, and dementia (Natale, Albertazzi, Zini, & Di Micco, 2001; Nilsen & Brinton, 
2002; Sherwin, 1991; 2008). However, the addition of T to ERT can ameliorate 
symptoms of low libido in both surgically and naturally menopausal women (Burger, 
Hailes, Menelaus, Nelson, Hudson, & Balazs,1984; Burger, Hailes, Nelson & Menelaus, 
1987; Sherwin & Gelfand, 1987; Sherwin, Gelfand, & Brender, 1985). Furthermore, 
premenopausal women with low androgen levels also report low libido, lack of energy 
and reduce feelings of well-being, despite adequate E levels, in a syndrome known as 
Androgen Insufficiency Syndrome (Bachmann et al., 2002). Androgen replacement 
therapy has been shown to restore libido in these women (Bachmann et al., 2002). The 
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mechanism underlying how the combined actions of Es and androgens work together to 
improve desire, however, has yet to be determined. 
Studies in nonhuman primates have also shown that androgens can facilitate 
female appetitive sexual behaviors, defined as female initiated sexual interactions (Beach, 
1976). Work in ovariectomized (OVX) rhesus monkeys has found that testosterone 
propionate (TP) increases appetitive behaviors, both through intramuscular injections 
(Wallen & Gow, 1977), and by its administration to the preoptic area of the 
hypothalamus (POA; Everitt & Herbert, 1975). 
Testosterone has been shown to effect female sexual function in the rat, both in 
terms of reproductive organs and sexual behaviors. Studies dating back to the 1930s, 
show that TP is important in maintaining reproductive organs (Baum, Sodersten, & 
Vreeburg, 1974; Korenchevsky Dennison, & Hall, 1937; Traish, Kim, Min, Munarriz, & 
Goldstein, 2002; Traish, Kim, Stankovic, Goldstein, & Kim, 2007; Whalen & Hardy, 
1970) and sexual behavior (Baum, Sodersten, & Vreeburg, 1974; Butler, Mills, & Bloch, 
2001; de Jonge, Eerland, & van de Poll, 1986; Fernandez-Guasti, Vega-Matuszczyk, & 
Larsson, 1991; Gladkova & Karpenko,1986; Whalen & Hardy, 1970). 
Testosterone as a bisexual hormone 
With the emergence of sexual dimorphism in regions of the brain that control 
sexual behavior and reproduction (e.g., the mPOA; Gorski, Gordon, Shryne, & Southam, 
1978; Hines, Davis, Coquelin, Goy, & Gorski, 1985; Jacobson & Gorski, 1981), 
androgens became popularized as "male sex steroids" and Es as "female sex steroids" 
(e.g. Machowska, Szlachcic, Pawlik, Brzozowski, Konturek, Pawlik, 2004). This 
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"gender-specific" role of sex steroids developed, despite work showing that E is 
important in male sexual behavior (Clancy, Zumpe, & Michael, 2000; Roselli, Cross, 
Poonyagariyagorn, & Stadelman, 2003) and that androgens are important in the 
development of female reproductive organs (Korenchevsky, Dennison, & Eldridge, 1937; 
Korechevsky & Hall, 1937). 
Korenchevsky's group published an extensive paper describing differential effects 
of various hormones on male and female reproductive tissue, classifying certain 
androgens (i.e. androsterone, TP, androstenediol) as partial bisexual hormones, and T as 
a true bisexual hormone, affecting both male and female tissues. The only pure hormone 
that was listed was P, as & purely 'female' hormone as it affected only female tissue 
(Korechevsky & Hall, 1937). When administering TP to OVX females, TP alone and in 
combination with E increased uterine weight and hypertrophy of the vagina and clitoris 
(Korenchevsky, Dennison, & Eldridge, 1937). 
Androgens have also been shown to stimulate both appetitive and consummatory 
sexual behaviors such as lordosis (a reflexive arching of the back by the receptive female 
in response to flank stimulation) in female rats. However the goal of most of these studies 
was to test their effects in combination with P, or to test the effects of hormones on 
mounting (a male sexual behavior). And although some studies have found that TP 
increases appetitive sexual behaviors (Fernandez-Guasti, Vega-Matuszczyk, & Larsson, 
1991; Gladkova & Karpenko,1986), these studies have not been followed up. 
Furthermore, the route and frequency of the androgen administration were inconsistent 
from one study to the next. 
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Whalen and Hardy (1970) showed that T can induce lordosis by the daily 
subcutaneous injection of TP (in doses of 100 j,ig, 500 ^g, or 1000 ug) to OVX female 
rats, but that this effect was further facilitated by a P injection given 4 hours prior to the 
test. Butler et al. (2001) administered TP via subcutaneous capsules and primed females 
with EB for 3 consecutive days, up to 29 hours prior to behavioral testing. Their results 
showed that TP when administered with estradiol benzoate (EB) induced similar lordosis 
reflexes as seen in fully primed EB+P treated animals. However the purpose of their 
study was to investigate the inhibition of lordosis in male rats following androgen and P 
treatment. Consequently, no further investigations into this effect were made. 
Satou and Yamanouchi (1998) reported that TP dose-dependently induced 
lordosis in OVX female rats when administered 48 hours prior to the test, and that P 
could inhibit TP's effect when administered 4 hours prior to a sexual behavior test. 
Others have found that TP induced female sexual behaviors when given alone or in 
combination with P (de Jonge, Eerland, & van de Poll, 1986). In the latter study, TP was 
administered daily for 14 days prior to the sexual tests and in contexts that had been 
shown to stimulate aggressive behaviors (de Jonge, Eerland, & van de Poll, 1986; van de 
Poll, van Zanten, & de Jonge, 1986). 
A few studies have examined the effects of androgens (i.e. TP, dihydro-
testoterone, dihydrotestosterone propionate) on female rat mounting and receptive 
behaviors. Baum, Sodersten and Vreeburg (1974) studied the effects of these androgens 
on mounting behavior in the female to further understand the mechanisms controlling 
mounting in the male (Baum, Sodersten, & Vreeburg, 1974). The authors used a 200 ug 
dose of TP, by daily subcutaneous injection (6 hours prior to behavioral testing), and 
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among various results, they reported low levels of receptivity in all TP-treated females in 
the presence of a stimulus male. The aim of the study however, was to study mounting 
behaviors induced by androgens, and consequently, the finding of TP-induced female 
receptivity was not followed up. 
Donahich and Clemens (1983) found that dihydrotestosterone (DHT) antagonized 
E-activated lordosis in the female rat complementing work by Erskine (1983), which 
suggested that DHT decreases the duration of female behavioral receptivity. Others have 
shown that anabolic androgenic steroids inhibit EB-induced sexual receptivity in OVX 
female rats treated with EB+P (Blasberg & Clark, 1997). However, not all compounds 
had this effect, for instance, testosterone cypionate did not inhibit lordosis, and the 
authors failed to investigate the effects of these androgens on appetitive behaviors. 
Subsequent studies did not investigate the effects of testosterone cypionate, as they were 
interested in the compounds that inhibit EB-induced sexual behaviors (e.g. Blasberg, 
Robinson, Henderson, & Clark, 1998). 
Interestingly, other groups have shown that certain androgens can facilitate 
appetitive behaviors in female rats that have been OVX and/or adrenalectomized (ADX). 
Gladkova and Karpenko (1986) reported that administration of androgens such as DHT 
and testosterone dipropionate to OVX female rats had no effect on lordosis, but elicited 
high levels of appetitive behaviors. Others have found that adding TP to OVX+ADX 
animals treated with EB+P resulted in significantly more appetitive behaviors (i.e. 
hops/darts and ear wiggling) compared to OVX+ADX animals treated with EB+P alone 
(Fernandez-Guasti, Vega-Maruszczyk, & Larsson, 1991). 
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Thus, the effects of T on the full display of female sexual behaviors in the rat 
have been scarce. The studies that have investigated the effects have been done so in a 
variety of contexts that do not necessarily favor the study of its direct effects on female 
sexual behaviors, and have often been designed to study the underlying mechanisms of 
male sexual behavior. 
The ovulatory cycle and sexual behavior in the rat 
In the female rat, sexual behaviors coincide in time with the period of high 
fertility (around the time of ovulation). The full display of appetitive and consummatory 
sexual behaviors in female rats is traditionally believed to depend on the sequential 
actions of E and P. These steroids activate protein synthesis in the hypothalamus and 
limbic system, two regions that underlie the activation of different neurochemical 
systems that excite sexual behaviors (Pfaff, 1999). 
The hormonal profile of the ovarian cycle across species is quite similar, 
particularly around the time of ovulation (McCarthy & Becker, 2002). The ovulatory 
cycle refers to the cyclic release of hormones from the ovaries, which are stimulated by 
the pituitary hormones LH (leutinizing hormone) and FSH (follicle-stimulating 
hormone), and are under the control of GnRH (gonadotropin releasing hormone) released 
from the hypothalamus. Varying concentrations of the estrogen estradiol (E2) and P from 
the ovary feedback onto the hypothalamus, stimulating or inhibiting GnRH release. The 
cyclical release of steroid hormones over the estrous cycle has been described through 
steroid concentrations in the blood and ovaries. Butcher, Collins and Fugo (1974), and 
Nequin, Alvarez, and Schwartz (1979) have described the cyclical variations in plasma 
hormone and gonadotropin levels throughout the estrous cycle of the rat. In addition, 
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radioimmunoassays have been used to measure steroid hormones over the estrus cycle 
both in plasma and the ovary (Belanger, Cusan, Caron, Barden, & Dupont, 1981). 
Varying steroid hormone concentrations also affect the structure of vaginal epithelial 
cells. 
In the rat, the phases of the estrous cycle (Diestrus, Proestrus, Estrus and 
Metestrus) can be monitored through the collection of vaginal epithelial cells (Hubscher, 
Brooks, & Johnson, 2005; Long & Evans 1922; Marcondes, Bianchi, Tanno, 2002). One 
cycle typically lasts 4-5 days in a young sexually mature animal. Animals on 5-day 
cycles either have an extra day of Estrus or Diestrus. During Diestrus, which lasts about 
55-57 hours (Hubscher, Brooks, & Johnson, 2005), ovarian follicles have FSH but not 
LH receptors. The pituitary releases small amounts of FSH and LH at this stage, 
stimulating follicular growth. Low levels of E2 and P are released from the follicles at 
this stage (McCarthy & Becker, 2002). A Diestrus vaginal smear consists of mainly 
leukocytes (Marcondes et al, 2002). The Proestrus phase is characterized in a vaginal 
smear as a predominance of round nucleated epithelial cells, and lasts about 12-14 hours 
(Hubscher, 2005; Marcondes, 2002). As the follicle grows increasingly large, there is a 
sudden rapid increase in E2 release, which feeds back on the hypothalamus, stimulating 
GnRH release leading to elevated levels of FSH and LH from the pituitary. The follicles 
have LH receptors at this point and can respond to the characteristic LH surge. The 
increase in LH concentration sets the stage for the final maturation of the follicle. 
Progesterone also peaks during Proestrus, approximately 4-6 hours after the E2 peak 
(McCarthy & Becker, 2002). Interestingly, theca and granulosa cells isolated from rat 
ovarian follicles during Proestrus produce several androgens, including T (Belanger et al., 
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1981; Fortune & Armstrong, 1977), and do so under the influence of LH (Fortune & 
Armstrong, 1977). This suggests that the ovaries secrete androgens during the period of 
heightened sexual responsivity. 
Female rats become receptive in late Proestrus and remain receptive for 12-20 
hours, depending on whether or not she is mated (McCarthy & Becker, 2002). This 
period of receptivity overlaps with the Estrus phase, a phase that lasts about 25-27 hours 
(Hubscher, Brooks, & Johnson, 2005). Ovulation occurs when the follicle ruptures and 
releases the secondary oocyte, between 36-48 hours after the increase in E, and 4-6 hours 
after the increase in P (McCarthy & Becker, 2002). Irregularly shaped, anucleated, 
cornified epithelial cells characterize Estrus vaginal cell morphology. Elevated levels of 
E inhibit the release of GnRH from the hypothalamus, keeping LH and FSH levels low. 
During Metestrus, which lasts 6-8 hours (Hubscher, Brooks, & Johnson, 2005), 
and in the absence of fertilization, the corpus luteum disintegrates, resulting in a sharp 
decline in E2 and P levels. This ceases the inhibitory effects caused by their high 
concentrations (McCarthy & Becker, 2002). The pituitary begins to release FSH again, 
stimulating the growth of new follicles in the ovary. At this stage, leukocytes begin to 
infiltrate the vaginal epithelium and the presence of nucleated cornified and leukocytic 
cells are present in the vaginal smear. 
The typical sexual behaviors of the female rat in behavioral Estrus are comprised 
of appetitive and consummatory behaviors. Appetitive behaviors are typically distal 
actions that serve to entice the male to chase or mount her. Ear wiggling (caused by rapid 
movement of the head), hopping and darting (sudden forward movement with abrupt 
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stops) and solicitations, defined as a female making a headwise orientation followed by a 
runaway. Consummatory behaviors refer to lordosis, a reflexive dorsiflexion, which 
occurs in response to flank stimulation by the male. Appetitive and consummatory 
behaviors are interspersed across the copulatory bout. Appetitive behaviors begin to 
decline and rejection responses (e.g. kicking and boxing the male) increase as the number 
of intromissions (penile insertion into the female's vagina) from the male increase prior 
to the decline in lordosis magnitude or frequency; this pattern of behaviors is 
characteristic of Estrus termination (Pfaus, Smith, Byrne, & Stephens, 2000). A decline 
in occupied P receptors in the hypothalamus has been shown to be involved in Estrus 
termination (Blaustein & Feder, 1979; Brown & Blaustein, 1984; Brown, Moore, & 
Blaustein, 1987). 
Sensory stimuli can alter the duration of Estrus. Behavioral Estrus persists for 
approximately 12 to 20 hours however experimentally-applied vaginocervical stimulation 
(VCS) or paced copulation shortens the duration of this phase (Blandau, Boling, & 
Young, 1941; Erskine, 1985; Erskine, Kornberg, & Cherry, 1989; Pfaus, Smith, Byrne, & 
Stephens, 2000). In addition, during the evening of Proestrus, and in OVX rats given 
steroid priming, paced mating has been showed to accelerate Estrus termination 
(Coopersmith, Candurra, & Erskine, 1996; Erskine & Baum, 1982). Vaginocervical 
stimulation that the female receives during multiple paced intromissions sends signals to 
the brain that activate reward mechanisms, satiety, analgesia and facilitate sperm 
transport. This stimulation also activates nightly prolactin surges which serve to maintain 
the secretion of P from the corpora lutea, ensuring implantation in the case of pregnancy, 
or inducing a two-week pseudopregnancy (Erskine, 1989; Matthews & Adler, 1978). 
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Sensory stimulation can also alter ovulatory patterns in aged females. Middle-aged 
females in persistent Estrus, a time when E concentrations are elevated and the LH-surge 
is disrupted resulting in anovulation, can begin cycling and ovulating again following 
caging and mating with a male, though reproductive success is reduced (Day, Morales, & 
Lu, 1988). 
Removing the ovaries from a rat leads to a rapid depletion of ovarian steroid 
hormones. Other peripheral tissues, such as the adrenals and adipose tissue, produce these 
hormones; however their levels are relatively low and delivered in a continuous, non-
cyclical fashion, blunting estrous cycles (Boling & Blandau, 1939; Hubscher, Brooks, & 
Johnson, 2005; Stockard & Papanicolaou, 1917). Ovariectomized rats do not display any 
sexual behavior or sexual interest (Beach, 1942). Behavioral Estrus can be induced in the 
OVX rat by sequential administration of E2 48 hours and P 4 hours prior to testing 
(Boling & Blandau, 1939; Beach, 1942; Whalen, 1974). 
In the OVX rat, a sufficiently high dose of E2 can induce lordosis and low levels 
of appetitive behaviors, however E2 followed by P is much more effective, producing the 
entire pattern of behavior observed in gonadally-intact rats in sexual "heat" (Boling & 
Blandau, 1939; Beach, 1942). Whalen (1974) administered varying doses of both E2 and 
P and showed that P mainly affected appetitive behaviors such as solicitations, hops, 
darts and ear wiggling, and suggested that E2 and P have differential effects on the 
induction of these behaviors. 
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Effects of aging on ovarian cyclicity and the sexual behavior of the female rat. 
Evidence suggests that the changes in ovarian cyclicity associated with age are 
due to alterations in the function of certain hypothalamic regions. When monitoring 
vaginal cytology, the female rat begins to show irregular cycles at approximately 8 
months of age, persistent Estrus at approximately 10 months of age, and persistent 
Diestrus at approximately 17 months of age (Lefevre & McClintock, 1988). The ovaries 
from aged, acyclic females, when transplanted into young OVX females, cause young 
animals to begin cycling normally again, however the reverse transplant of young ovaries 
into aged females does not restore cyclicity (Aschheim, 1961; Peng & Huang 1972; 
Felicio, Nelson, & Finch, 1986). 
Sexual behaviors in aging female rats decline with age, as the hormonal profile of 
the Estrous cycle is disrupted (Borchardt, Lehman, & Hendricks, 1980; Chamber & 
Phoenix, 1986; Gerall, Dunlap, & Sonntag, 1980; Huang, Steger, Bruni, & Meites, 1978). 
Females in persistent vaginal estrous reportedly continue to display normal lordosis 
quotients (Borchardt et al., 1980; Cooper & Linnoila, 1977), whereas appetitive 
behaviors (e.g. hops and darts) are significantly attenuated (Borchardt et al., 1980). 
Chambers and Phoenix (1986) investigated the effect of OVX and EB+P priming on aged 
(13 months old) versus young (4.5 months) female rats. They found no effect of age on 
consummatory aspects (i.e. lordosis) whereas appetitive behaviors (e.g. hops and darts) 
were significantly attenuated in these aged animals. A decline in appetitive behaviors in 
aged animals is consistent with the findings of Borchardt and colleagues (1980) 
mentioned above, and is reminiscent of the behavioral patterns occurring in females in 
Estrus termination. 
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Cooper, Conn and Walker (1980) found that the LH surge in middle-aged (10.5 
months) rats is delayed and lower in amplitude compared to young (4.5 months) 4-day 
cycling rats. As discussed in Cooper et al. (1980), GnRH release may be disrupted in 
aged females, in turn disrupting LH release. These aged-dependent changes can be 
attributed to three factors: First off, middle-aged females have lower circulating P levels 
on the evening of Proestrus, however an injection of P on the morning of Proestrus has 
been shown to increase the LH surge (Miller & Riegle, 1979). Secondly, OVX of a young 
female rat leads to high circulating gonadotropin levels, due to a loss in ovarian steroid 
negative feedback mechanisms. In middle-aged animals, the gonadotropin levels are 
increased, but not to levels of young females, suggesting a disruption in the gonadotropin 
feedback mechanisms (Gray et al., 1980). Furthermore, the administration of E to OVX 
middle-aged animals leads to an LH surge lower in amplitude when compared to young 
OVX females treated with E. Finally, given that lesions to the suprachiasmatic nucleus of 
the hypothalamus (SCN) impair gonadotropin secretion and ovarian cyclicity (Brown-
Grant & Raisman, 1977), age-related changes in the circadian rhythms from the SCN 
may be reducing GnRH stimulation, resulting in lowered LH surges (Cooper, Conn, & 
Walker, 1980; Matt, Coquelin, & Lu, 1987; Rubin, 2000). 
Additional support relating the SCN to age related changes in the female rat 
comes from the work of Cai and Wise (Cai, Scarbrough, Hinkle, Wise, 1997; Cai, 
Lehman, Lloyd, Wise, 2007), who that show that diurnally-induced Fos expression (a 
marker of cell activity) in the SCN is disrupted in middle-aged rats. In aged females, 
baseline Fos expression occurs earlier, during the dark-cycle, and light-induced Fos 
expression is attenuated and delayed. However, transplantation of fetal SCN tissue into 
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the third ventricle of middle-aged rats restores the pattern of Fos expression to levels 
equivalent to that observed in young females. These data raise the possibility that GnRH 
may be disrupted by changes in the SCN, resulting in disturbances in the pulsatile release 
of FSH and LH from the pituitary, in turn causing detrimental effects on ovarian follicles 
and eventually leading to a termination in normal ovarian functioning (Wise, 1999). 
Protein synthetic effects of estrogens and androgens 
Androgen and E receptors are situated in the cytosol. Upon binding to their 
ligands, migration of the receptor from the cytosol to the nucleus occurs before binding to 
the hormone response elements of DNA. This causes a cascade of events that ultimately 
lead to protein synthesis. Estrogens have been correlated with female reproductive 
function both spatially and temporally (Pfaff, 1980). Estrogen is required to prepare the 
brain for sexual behaviors, which takes a minimum of 16-20 hours to take effect (Green, 
Luttge, Whalen, 1970; McEwen, Pfaff, Chaptal, & Luine, 1975). The ventromedial 
nucleus of the hypothalamus (VMH), anterior hypothalamus (AH) and medial preoptic 
area of the hypothalamus (mPOA) are brain regions that have high concentrations of Es, 
P, and androgens receptors, and in which exogenous E2 applied directly to these areas 
can facilitate female sexual behaviors (Pfaff, 1980). Lisk (1962) discovered that E2 
administered directly into the mPOA of the hypothalamus activated lordosis in OVX 
females. Subsequently, it was found that the VMH of the hypothalamus was even more 
sensitive to E2 (Davis, Krieger, Barfield, McEwen, Pfaff, 1982; Dorner, Docke and 
Mustafa, 1968; Parsons, Rainbow, Pfaff, & McEwen, 1982). 
Temporally, the actions of E are a slow process, triggering genomic effects to 
transcribe proteins and upregulate P receptors, in areas such as the mPOA and VMH 
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(MacLusky & McEwen, 1978), so that P can bind its receptor and facilitate appetitive 
aspects of sexual behavior. The eventual decrease in occupied P receptors in the 
hypothalamus is involved in Estrus termination. Progesterone is also important in the 
ventral tegmental area (VTA) in the control of lordosis, by acting on dopamine (DA) 
and/or GAB A receptors (Frye, 2001; Frye & Waif, 2008). 
In female OVX rats, brought into behavioral Estrus via subcutaneous injection of 
EB and P, 48 and 4 hours before the test, respectively, the neurotransmitter DA is 
reportedly increased in the mPOA, at the time that they would normally begin displaying 
sexual behaviors, in the absence of any sensory stimulation from a male (Matuszewich, 
Lorrain, Hull, 2000). A further increase in mPOA DA release occurs when a mate is 
introduced into the cage and copulation begins. In EB-primed OVX rats, DA agonists 
facilitate sexual behaviors (Melis & Argiolas, 1995). This is evidence that DA in the 
mPOA is important in both appetitive and consummatory aspects of female sexual 
behavior. Similarly, DA is increased in the nucleus accumbens (NAcc) of EB+P primed 
female rats when a male is introduced in the testing chamber, and DA is further increased 
in conditions where the female is allowed to pace the timing between intromissions 
(Becker, Rudick, Jenkins, 2001). 
Testosterone's effects in the control of male sexual behavior and DA release have 
been extensively studied in rats (Hull, Du, Lorrain, Matuszewich, 1997; Hull, Lorrain, 
Du, Matuszewich, Lumley, Putnam, Moses, 1999). The mPOA is a critical brain site 
involved in male sexual behavior. Stimulating the mPOA increases the rate of copulation 
and blocking it decreases copulation (Hull, Bitran, Pehek, Warner, Band, & Holmes, 
1986; Warner, Thompson, Markowski, Loucks, Bazzett, Eaton, & Hull, 1991). Castration 
15 
is the surgical removal of the testicles which are the main source of T synthesis; 
castration leads to impaired copulatory behaviors in male rats. Testosterone increases 
nitric oxide synthase (NOS) in the mPOA, in turn stimulating DA release, leading to 
erection of the penis in castrated male rats. (Du & Hull, 1999; Hull et al., 1999). 
Since T can either be reduced to the androgen DHT, or aromatized to E2, 
researchers have studied the effects of E2 on male sexual behavior. It has been 
established that aromatase-containing neurons in the mPOA (and elsewhere) are causally 
related to the effect of androgens on the sexual behavior of male rats (Putnam, Sato, 
Riolo, & Hull, 2005), as aromatase inhibition disrupts male sexual behaviors, and the 
application of crystalline E2 to the mPOA can restore mounting in castrated males (Lisk 
& Bezier, 1980). Thus, T has been shown to be important in the release of DA, a 
neurotransmitter involved in sexual motivation and function in both males (Bazzett, 
Lumley, Bitran, Markowski, Warner, & Hull, 1992; Hull, Lorrain, Du, Matuszewich, 
Lumley, Putnam, & Moses, 1999) and females (Becker, Rudick, & Jenkins, 2001). The 
role of DA is also particularly important in areas involved in sexual behavior, such as the 
VMH, mPOA, NAcc and the VTA in both males and females. Given that researchers 
have investigated the role of E in male sexual behaviors, it is surprising that the study of 
T on female sexual behaviors has been so limited. 
The goal of the present thesis was to study the effects of TP given with or without 
EB on both appetitive and consummatory sexual behaviors in both the young OVX and 
aged intact female rat. 
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Outline of experiments 
Very few studies have investigated the effects of TP on the appetitive and 
consummatory aspects of female sexual behavior in OVX rats. Even fewer are the studies 
that have looked at sexual behaviors in aging rodents, and how sexual behaviors can be 
maintained or restored with exogenous hormone treatments. This has perhaps been 
difficult because institutions often impose a high cost on the care and maintenance of 
laboratory animals. Retired breeder females from breeding farms are quite expensive, 
and their sexual history is usually unknown. 
Therefore, the present thesis explored the way in which TP treatment either alone 
or in combination with EB, would affect appetitive and consummatory aspects of female 
sexual behavior. The overarching hypothesis was that co-administration of EB and TP 
would facilitate sexual behavior, in particular appetitive behaviors (i.e. solicitations, hops 
and darts) in young OVX and aged intact animals. The optimal dose and schedule of 
administration was not clear however, thus dose-responses and varying methods of 
administration were examined. 
Experiment 1 tested whether there is a dose-response relationship to varying TP 
levels, given with or without EB, on the sexual behaviors of young OVX females. Results 
from this study would allow us to determine if there is a critical amount of TP required to 
elicit an effect, to help understand whether high levels of androgens are being aromatized 
to estrogens, thus restoring some behaviors and whether the addition of EB to a TP 
regimen would contribute to TP's effect. Experiment 1 also compared the effects of TP 
treatments to EB+P, a regimen that is known to fully restore female sexual behaviors in 
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OVX rats. The results of this experiment allow us to understand the magnitude of the 
effect (if any) of TP on female sexual behavior. 
Experiment 2 investigated the acute and chronic effects of TP given with or 
without EB, on the sexual behaviors of aged female rats. The route of administration was 
via subcutaneous injection over 4 day intervals. Results from these studies would 
determine whether or not EB and TP facilitate sexual behaviors in aged animals, and 
whether or not the effects are maintained over time. 
Experiment 3 investigated the behavioral effects of chronic TP administered at a 
constant rate, by subcutaneous capsules in varying doses, either alone or following 
chronic EB. The results of these experiments help to determine whether the route of 
administration, schedule of exposure and dose of TP elicit differential effects (compared 
to Experiment 1), and whether acute (Experiment 2 Phase 1) versus chronic treatment 
(Experiment 2 Phase 2) maintains, facilitates, or inhibits treatment efficacy. In addition, 
the results help to determine whether either hormone alone is sufficient in maintaining an 
effect. 
All experiments were carried out in accordance with the ethical standards 
established by the Canadian Council on Animal Care (CCAC), and were approved by 
Concordia University's Animal Research Ethics Committee. 
18 
Experiment 1: Young OVX 
Introduction 
Studies showing that TP induced lordosis in OVX female rats have used a 200 ug 
dose of TP injected subcutaneously 6 hours prior to the test (Baum, Sodersten & 
Vreeburg, 1974). Because we were interested in the restoration of appetitive behaviors as 
well as consummatory behaviors, a dose-response study of TP both alone and following 
EB, was performed in OVX Wistars to investigate whether there was an optimal dose of 
TP in the restoration of female sexual behaviors in OVX rats. In addition, because EB+P 
restores all aspects of female sexual behaviors, this group was used as a comparison 
when investigating the effects of varying hormone treatments on female sexual behavior. 
Experiment 1 was performed in 3 phases. Phase 1 investigated the effect of 
varying TP doses on sexual behaviors in OVX female rats. Phase 2 took these same 
animals and investigated varying TP doses when animals were exposed to a common EB 
dose 48 hours prior. Phase 3 separated the animals into 4 groups of varying hormone 
treatments, where a 200 ug dose of TP was used, concurrent with the dose shown to 
induce lordosis in earlier studies (Baum, Sodersten & Vreeburg, 1974). These 
experiments were run in sequence, separated by 4 day testing intervals. 
Method 
Subjects. 
Fifty Wistar female rats (200-250 g, approximately 10 weeks old) were purchased 
from Charles River Canada (St. Constant, Quebec). Animals were caged in groups of five 
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in stainless-steel cages in a colony room maintained at 21°C and on a 12-hour reverse 
day-night cycle (lights off at 8AM). Food and water were freely available. 
Forty Long-Evans males were used as stimulus animals. Males were 
approximately 4 months old at the time of the test, were caged in groups of 4 and were 
sexually experienced in bi-level chambers. 
Ovariectomy. 
Animals were given one week of acclimatization to the animal colony prior to 
OVX. Surgeries were done under a mixture of ketamine hydrochloride (50 mg/mL) and 
xylazine hydrochloride (4 mg/mL) (4:3) injected intraperitoneally (1 mL/kg body 
weight). When anesthetized animals no longer had a reflex to a foot pinch, they were 
OVX bilaterally with a single lumbar incision. Post-operative care was given with 0.03 
mL each of Banamine and Baytril, followed by 3 mL saline solution, and polysporin was 
applied to the incision site. Animals were allowed one-week post-surgical recovery prior 
to sex training. Six animals were lost following surgery prior to the start of the 
experiment due to unknown reasons, resulting in 44 animals available for the experiment. 
Experimental procedure. 
Behavioral tests were carried out in the bi-level chamber (Figure 1), which is 
rectangular in shape (70 cm x 51 cm x 15 cm), with two distinct platforms and stairways 
on either side, allowing the female to change levels and temporarily escape from the 
male, pacing the rate of copulation. The advantage of this type of chamber is it orients the 




Figure 1. Bi-level chamber. Dimensions of 70 cm (length) x 51 cm (height) x 15 cm 
(width). The advantage of using this chamber is it orients the animals lengthwise, 
allowing the observer to clearly see the behaviors. 
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and permits females to fully express both appetitive and consummately sexual behaviors 
(Pfaus, Smith, & Coopersmith, 1999). 
Males were always placed first on the bottom level of the bi-level chamber for a 
five-minute habituation period to the chamber. Females were subsequently placed in the 
chamber onto the top level, for a 30-minute test session. Testing sessions were recorded 
by a videocamera onto a DVD-writable disc for subsequent scoring using the Behavioral 
Observation Program customized for rat sexual behavior (Cabilio, 1996). 
Females were hormonally primed with EB (10 ug) 48 hours, and P (500 (ig) 4 
hours prior to each of 4 training sessions, separated by 4 day intervals. A 12-day washout 
period was allowed between the final training and first testing sessions. The experimental 
phases were separated by 4-day intervals. Animals were always tested during the middle-
third of their dark cycle. 
Behavioral analyses 
Female appetitive behaviors include solicitations, defined as a headwise 
orientation towards the male followed by a runaway, hops which consist of quick 
hopping motions in proximity of the male, and darts defined as a runaway followed by an 
abrupt stop. These behaviors were grouped as one measure termed "appetitive 
behaviors". Level changes were scored when the female changed a complete level (all 
four paws touched the upper or lower level of the chamber). 
Lordosis is a consummatory sexual behavior defined as a reflexive arching of the 
back in response to flank stimulation (such as mounting by a male). Lordosis magnitudes 
(LM) were broken down into a three-point scale depending on the magnitude of the 
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curvature of the back between the head and tail, as described by Hardy and DeBold 
(1971). A straightening of the spine is scored as the lowest LM of 1, flexion of the back 
with slight elevation of the head at an approximate angle of 30 degrees, is scored as LM 
2, and spinal curvature with the head at a 45 degree angle or more is rated as LM 3. A 
lordosis quotient (LQ) was calculated for the whole test session by taking the ratio of the 
sum of all LMs to the sum of mounts, intromissions and ejaculations (LM / mount + 
intromission + ejaculation). Defensive behaviors (kicks, sideways takedowns, boxing 
postures, prone positions, as in Barnett, 1967) displayed by the females against the males 
were scored per incident. 
Male behaviors were included in the behavioral analyses, as they provide further 
insight of the females' responses and can often be taken as an indication of the females' 
level of receptivity (Pfaus, Smith, Coopersmith, 1999). All male behaviors included 
mounts (male's front paws on female's flanks), intromissions (the male displays a 
characteristic "kickback" on the dismount) and ejaculations (the follow-through of the 
mount results in a strong pelvic thrust and maintaining a grasp on the female's flanks) 
were scored, to complement the females' behavior, including appetitive and 
consummatory behaviors. 
Phase 1: TP-alone. 
Hormonal procedure 
Females were taken off all exogenous hormone treatments for a total of 12 days 
prior to the experimental test. On test day, females were separated into 5 groups of 
varying TP doses (administered and scored blindly) in a 0.1 mL volume of sesame oil 
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injected s.c. 4 hours prior to the experiment: 0 u£ (n=9), 50 |!g (n=9), 100 u.g (n=9), 200 
ug (n=9) and 400 (ig (n=8) and were tested for sexual behavior in bi-level chambers with 
sexually experienced males. TP doses were administered and scored blindly. 
Statistical analyses 
All test statistics were run using SPSS 16.0 for Windows, using one-way between 
subjects ANOVAs, and Tukey's post-hoc test analyzed differences between groups. The 
level of significance for all comparisons was p < .05. Group descriptive statistics are 
represented as mean (M) +/- standard error of the mean (SEM). 
Results 
The ANOVA failed to detect significant differences between any of the TP 
groups, and very few behaviors were recorded overall. Any behavior that occurred during 
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Figure 2. Frequency of sexual Behavior of OVX Wistar rats treated with varying doses of 
TP. Doses of TP (0, 50, 100, 200, 400 ug) were injected s.c 4 hours prior to the test. 
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Phase 2: TP with common EB baseline. 
Hormonal procedure. 
Two days following the TP-alone study, the same females were injected s.c. with 
EB (10 u.g) to be tested 48 hours later for sexual behavior. Animals remained in the same 
groups, receiving the same TP doses as the TP-alone study (0 ug, 50 ug, 100 fig, 200 u.g 
400 ug), to which the experimenter was blind. One animal from the 400 ug dose of TP 
group escaped the chamber, thus was excluded from the analysis, resulting in a group size 
of 7. 
Statistical analyses 
One-way analysis of variance (ANOVA) was run on each behavior, and Tukey's 
post-hoc test determined specific group differences, following a significant overall 
ANOVA. The level of significance for all comparisons was p < .05. Group descriptive 
statistics are represented as mean (M) +/- standard error of the mean (SEM). 
Results. 
Although all the animals did show sexual behaviors, there were no significant 
differences between any of the doses. Figure 3 shows the mean frequency of male 
behaviors towards the female, female appetitive behaviors are represented in Figure 4, 

































Male Level Changes 
EB + O EB + 50ugTP EB+lOOugTP EB + 200ugTP EB + 400 ug TP EB + O EB + 50 ug TP EB + 100 ug TP EB + 200 ug TP EB + 400 ug TP 
Figure 3. Frequency of male sexual behaviors towards Wistar OVX female rats treated 
with EB and varying doses of TP. EB (10 ug) injected s.c. 48 hours, and doses of TP (0, 
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Figure 4. Frequency of appetitive sexual behaviors of Wistar OVX female rats treated 
with EB and treated with varying doses of TP. EB (10 (j.g) injected s.c. 48 hours, and 
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EB + O EB + 50ugTP EB + lOOugTP EB + 200ugTP EB + 400ugTP EB + O EB + 50 ug TP EB + 100 ug TP EB + 200 ug TP EB + 400 ug TP 
Figure 5. Frequency of consummately sexual behaviors of Wistar OVX female rats 
primed with EB and treated with varying doses of TP. EB (10 |ig) injected s.c. 48 hours, 
and doses of TP (0, 50, 100, 200, 400 ug) injected s.c. 4 hours prior to the test. 
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Phase 3: Varying hormone regimens on sexual behavior of OVX rats 
Hormonal Procedure. 
Estradiol benzoate (EB) was dissolved in sesame oil and animals were injected 
s.c. 48 hours prior to the start of the experiment with 10 |ig in 0.1 mL sesame oil (O). 
Progesterone (500 ug) and TP (200 ug) were dissolved in sesame oil, and injected s.c. in 
a volume of 0.1 mL 4 hours prior to the start of the training sessions. All animals 
received two injections, the first 48 hours and the second 4 hours prior to behavioral 
testing with their respective treatment, control animals received 0.1 mL of sesame oil. 
The groups were administered test hormones as follows: O+O, EB+O, EB+P, O+TP and 
EB+TP. Each group consisted of 9 animals, except for O+TP which totaled 8. 
Results 
All behaviors were analyzed using a one-way ANOVA and are represented in 
Figures 6 (male behaviors toward female), 7 (female appetitive behaviors) and 8 (female 
consummatory behaviors). Significant effects are discussed in more detail below. 
Male behaviors 
A main effect of hormone regimen on intromissions was detected, F(4,39)=8.958, 
p=0.00. Tukey's post-hoc analyses revealed that females treated with O+O or TP-alone 
received fewer intromission than females treated with EB-alone, EB+P and EB+TP. 
A main effect of hormone regimen on ejaculations was also observed, F(4,39)= 
9.28, p=0.00. Post-hoc Tukey analyses revealed that females treated with O+O or TP-






























Male Level Changes 
o+o EB+O EB+P O+TP EB+TP 
Figure 6. Frequency of sexual behaviors of male rats towards Wistar OVX female rats 
following acute injections of various hormone treatments. O: sesame oil, EB: estradiol 
benzoate, 10 ug; P: progesterone, 500 ug; TP: testosterone propionate, 200 ug). Values 
are mean +/- SEM. * Different from O+O, p<.05; # different from O+TP, p<.05. 
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Appetitive Behaviors 










Female Level Changes 
o+o EB+O EB+P O+TP EB+TP 
Female Defenses 
o+o EB+O EB+P O+TP EB+TP 
Figure 7. Frequency of appetitive sexual behaviors of Wistar OVX female rats following 
acute injections of various hormone treatments. O: sesame oil, EB: estradiol benzoate, 10 
(j,g; P: progesterone, 500 ug; TP: testosterone propionate, 200 ug). Values are mean +/-
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O+O EB+O EB+P O+TP EB+TP 
Figure 8. Frequency of consummately sexual behaviors of Wistar OVX female rats 
following acute injections of various hormone treatments. O: sesame oil, EB: estradiol 
benzoate, 10 u.g; P: progesterone, 500 |ig; TP: testosterone propionate, 200 ug). Values 
are mean +/- SEM. * Different from O+O, p<.05; # different from O+TP, p<.05; + trend 
from EB+P, p<.10; ++ trend from O+TP, p<.10. 
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Female Appetitive Behaviors 
An overall main effect of hormone regimen was found for appetitive behaviors, 
F(4,39)= 12.40. Post-hoc analyses revealed that females treated with O+O or O+TP 
displayed significantly fewer appetitive behaviors than females treated with EB+P or 
EB+TP. 
Female Consummatory Behaviors 
An overall main effect of hormone regimen was found on LM 3, F(4,39)=l 1.831, 
p=.00, with post-hoc tests showing that females treated with O+O or TP-alone displayed 
significantly fewer LM 3 postures compared to females treated with EB+P or EB+TP. 
Discussion 
Phase 1 of Experiment 1 confirms that acutely, none of the tested doses of TP 
have an effect on sexual behaviors of young OVX rats. Males continued to mount the 
female, however no male successfully intromitted or ejaculated, probably due to the 
number of defensive responses (which have a similar mean value to the number of 
mounts, suggesting rejection from the female in response to the mounts). Furthermore, 
female defensive behaviors (kicks, prone position) were no different than the control 
group. This contradicts earlier work (Baum et al., 1974; Van de Poll, van Zanten & de 
Jonge, 1986) however the method of administration (interval of time between androgen 
administration and test session, route of administration, and dosing regimen) may explain 
this difference. Routes of administration may have different biological effects through the 
by-passing, for example, of hepatic metabolism in the case of transdermal routes versus 
oral routes of administration; the delay between injections and dosing regimen may also 
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differentially effect biological mechanisms, for example by upregulating or 
downregulating receptors, leading to changes in behavioral output. 
Phase 2 of Experiment 1 tested whether varying doses of TP, when added to a 
common EB baseline, would affect female sexual behavior. The administration of EB 
induced both appetitive and consummatory aspects of female sexual behavior, however 
no dose of TP added to the effect. 
Phase 3 of Experiment 1 tested whether varying hormone treatments affect sexual 
behaviors in young OVX Wistar female rats. These results suggest that EB+TP induces 
behavioral effects similar in magnitude to EB+P treated animals, though these effects 
were not statistically different from animals treated with EB-alone. It should also be 
noted that control animals in Experiment 1 Phase 3 were oil-treated; however, these 
animals continued to display low levels of both appetitive and consummatory sexual 
behaviors. This conflicts with the findings in Phase 1, where control animals failed to 
display any appetitive or consummatory aspects of sexual behavior. Similarly, animals in 
the TP-alone group of Phase 3 displayed low levels of sexual behaviors, which again 
conflicts with the results of Phase 1. Furthermore, animals in the EB+TP group were 
receiving 200 ug of TP, and although they also showed elevated levels of sexual 
behaviors, to levels similar to EB+P, this increase was only a trend when compared to 
EB-alone. This conflicts with reports in the literature, showing that the addition of P to an 
EB-treated animal induces significantly more appetitive behaviors and LQ's (Pfaus, 
Smith, & Coopersmith, 1999; Whalen, 1974). These results suggest that carry-over 
effects of TP received 4 and 8 days prior (for Phase 2 and Phase 1, respectively) and/or 
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EB administered 6 days prior to Phase 3 affected the behavior of these animals at Phase 
3. 
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Experiment 2: Aged Intact Phasic TP 
Introduction 
The goal of Experiment 2 was to introduce varying hormone treatments to intact, 
aged female rats to test whether TP, when administered with or without EB, would 
restore any aspects of female sexual behavior. A 200 ug dose was used, concurrent with 
the dose shown to induce lordosis in earlier studies (Baum, Sodersten & Vreeburg, 1974). 
Experiment 2 was designed in two phases. The first investigated the acute effects 
of varying hormones on sexual behaviors. The second phase investigated the long-term 
effects of TP when administered alone, or in combination with EB, on sexual behaviors. 
Method 
Subjects. 
Forty retired-breeders of the Wistar strain (ages ranged from 5-8 months) were 
obtained from Charles River, St-Constant, QC. Each had bore between 2-5 litters of 8-16 
pups. They were kept on a 12-hour reverse day-night cycle (lights off at 8 AM), with 
water and rat chow freely available. Animals were housed in shoebox cages in pairs when 
possible (i.e. odd numbers of animals resulted in animals caged alone), and identified 
with markings on the base of the tail. They were housed in shoebox cages for 18 weeks 
prior to the start of the study. 
Cell cytology 
The estrus cycles of all animals were monitored for 25 consecutive days prior to 
the start of the experiment (identification method similar to Marcondes et al., 2002), by 
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vaginal cell collection with a cotton swab slightly lubricated with distilled water. Cells 
were taken within the first hour of their dark cycle. All animals were no longer cycling 
over 4-5 days by the beginning of the experiment, and were approximately 9-12 months 
of age. 
Vasectomy. 
To prevent possible impregnation of intact females, 48 sexually experienced 
Long-Evans males (aged approximately 9 months old) were vasectomized under 
anesthesia by 1.5 cc per kg body weight with ketamine hydrochloride (50 mg/mL) and 
xylazine hydrochloride (4 mg/mL) (4:3) injected i.p. A single incision was made to the 
scrotal sac, followed an incision to the muscular sac of the testes, and by applying slight 
pressure to the abdomen, the testes were exposed and the vas deferens were located. The 
vas deferens was separated from the blood vessels, clamped and ligated with 2 ties of 
surgical thread approximately 5 mm apart, and cut on either side. Testes were left intact 
and returned to the scrotal sac, the muscle and skin incisions were sutured shut. Animals 
were allowed two weeks of recovery before being given two sexual experiences, every 4 
days with sexually experienced OVX Long-Evans female rats. All males were 
copulating, as determined by the expression of intromissions with the OVX females 4 
days prior to the start of the study. 
Experimental procedure 
The experimental procedure was identical to Experiment 1, without the EB+P 
training period, since animals were retired breeders. 
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Behavioral analyses 
The same behavioral measures that were observed in Experiment 1 were analyzed 
in Experiment 2. 
Phase 1: Acute effects of varying hormones on sexual behavior 
Hormonal procedures. 
Estradiol benzoate (EB) was dissolved in sesame oil and animals were primed 48 
hours prior to the start of the experiment with 10 jag in 0.1 mL sesame oil (O). 
Progesterone (500 ug) and TP (200 (ig) were dissolved in sesame oil, and injected s.c. in 
a volume of 0.1 mL 4 hours prior to the start of the sessions. All animals received two 
injections, the first 48 hours and the second 4 hours prior to behavioral testing with their 
respective treatment, control animals received injections of 0.1 mL of sesame oil. The 
groups were administered test hormones as follows: O+O (n=10), EB+O (n=6), EB+P 
(n=8), EB+TP (n=8). 
Statistical analyses. 
A one-way between subjects ANOVA was run for each behavior using SPSS for 
Windows (version 16.0), and Tukey's test was used for post-hoc comparisons. The level 
of significance for all comparisons was p < .05. Group descriptive statistics are 
represented as mean (M) +/- standard error of the mean (SEM). 
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Results. 
Of a total of 40 animals, 25 animals were in Proestrus or Estrus on test day, 7 
were in Metestrus, and 8 were in Diestrus. Any animal in Diestrus, or who resulted in a 
division by 0 for the LQ, suggesting the male was not copulating, were excluded from the 
statistical analyses. Females who were in Metestrus, also displayed appetitive and 
consummatory behaviors, thus were included in the statistical analyses. Five animals 
remained in the O+O group, 8 in the EB+O group, 8 in the EB+P group and 9 in the 
EB+TP group. 
Female Defenses 
There was a main effect of group on female defense, F(3,26)=3.227, p <.05. Post 
hoc analyses showed significantly more defensive behaviors O+O than the EB+O group. 
Lordosis Quotient 
There was a main effect of group on lordosis quotient F(3,26)=3.155, p<0.05. 
Post hoc Tukey analyses showed that 0 + 0 displayed significantly less LM in response to 
flank stimulation compared to EB+O animals. 
Although no further behaviors were statistically significant, the graphs of male 
behaviors towards the females (Figure 9), as well as female appetitive (Figure 10) and 
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Figure 9. Frequency of male sexual behaviors towards aged female Wistar rats following 
acute injections of different hormone regimens. (O: sesame oil, E: estradiol benzoate, 10 
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Figure 10. Frequency of defensive and appetitive sexual behaviors of aged female Wistar 
rats following acute injections of different hormone regimens. (O: sesame oil, EB: 
estradiol benzoate, 10 jag; P: progesterone, 500 ug; TP: testosterone propionate, 200 ug). 
Values are mean +/- SEM. * Significantly different from O+O *p<.05, Ap<.10. 
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Figure 11. Frequency of consummatory sexual behaviors of aged female Wistar rats 
following acute injections of different hormone regimens. (O: sesame oil, EB: estradiol 
benzoate, 10 ug; P: progesterone, 500 ug; TP: testosterone propionate, 200 ug). Values 
are mean +/- SEM. * Significantly different from O+O. p< .05, Ap< .10 
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Phase 2: Chronic administration ofTP alone or in combination with EB 
Hormonal procedures. 
Immediately following Phase 1, animals were separated into two groups where half 
the animals from each of the hormone groups in Phase 1 were assigned to the O+TP 
(n=20) and the other half to the EB+TP group (n=20). Testing began 4 days following the 
end of Phase 1, and continued for a total of 5 test sessions. 
Both groups received a TP dose of 200 ug dissolved in 0.1 mL sesame oil, and 
injected s.c. 4 hours prior to the start of the testing sessions. Animals in the EB+TP group 
also received 10 ug EB dissolved in 0.1 mL sesame oil injected s.c. 48 hours prior to the 
start of the experiment. 
Statistical analyses 
Animals who received only one mount or less were removed from the analyses, 
because it suggested that the male was not copulating normally. Removing an animal 
from one test resulted in eliminating that animal from all tests, which greatly reduced the 
group sizes. Consequently, a one-way between subjects ANOVA was run, by separating 
the animals into four groups, resulting in O+TP at trial 1 (Tl; n=14), O+TP at trial 5 (T5; 
n=l 1), EB+TP at Tl (n=18) and EB+TP at T5 (n=13). Tukey's post-hoc test was used to 
compare differences between groups. Significance levels were set at p<.05. 
Results 
The frequencies of sexual behaviors are presented in Figure 12 (male behaviors 





















































Figure 12. Frequency of male sexual behaviors towards aged female rats following 
chronic administration of TP-alone or EB+TP injected s.c. over 5 test trials. Bars 
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Figure 13. Frequency of appetitive sexual behaviors of aged female rats following 
chronic administration of TP-alone or EB+TP injected s.c. over 5 test trials. Bars 
represent frequency of behavior at baseline, trial 1 (Tl) and trial 5 (T5). * p <.05, # p > 
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Figure 14. Frequency of consummatory sexual behaviors of aged female rats following 
chronic administration of TP-alone or EB+TP injected s.c. over 5 test trials. Bars 
represent frequency of behavior at baseline, trial 1 (Tl) and trial 5 (T5). * p <.05, # p > 
.05 < .1. 
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consummatory behaviors). Baseline represents the control animals from the acute test 
(Experiment 1 Phase 1) as a comparison. 
Male behaviors. 
There was a main effect of hormonal regimen on mounts, F(3, 52)= 4.129, 
p=.011. Post-hoc Tukey tests revealed that females that received TP-alone on Tl 
received significantly more mounts than females that received EB+TP on T5. 
Female appetitive behaviors. 
There was a main effect of hormone regimen on appetitive behaviors, 
F(3,52=2.89, p=.044) however post-hoc tests detected only a trend between EB+TP at 
Tl, who had higher levels than EB+TP at T5 (p=.069). 
Female consummatory behaviors. 
A main effect was also detected for hormone regimen on LM 3, F(3,53)=6.085, 
p=.001. Post-hoc tests revealed that females that received TP-alone at Tl or EB+TP at 
Tl displayed significantly more LM 3s than females that received EB+TP on T5. 
Likewise, females that received EB+TP at Tl displayed significantly more LM 3s than 
females that received TP-alone on T5. There was also a main effect on LQ, showing that 
LQs at T5, for both females treated with TP-alon© or EB+TP were significantly 
attenuated compared to those same groups at Tl. 
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Discussion 
Aged, irregularly cycling female rats, when administered EB acutely, show 
increased LQs. EB also decreased the frequency of defensive behaviors. These results 
coincide with data in the current literature suggesting that E controls consummatory 
aspects of female rat sexual behavior. No other aspect of sexual behavior was affected by 
acute hormone treatment. 
When aged irregularly cycling female rats are administered chronic TP or EB+TP 
by subcutaneous injection, over time behaviors are attenuated in both groups. There is a 
time-dependent decrease in LQ regardless of treatment, where both TP-alone and EB+TP 
at Tl are no different from baseline, however at T5, both treatment groups display 
significantly fewer LMs in response to flank stimulation from the male. A similar pattern 
occurs for appetitive behaviors, where there is a time-dependent decrease, irrespective of 
treatment. These results suggest an activation of inhibitory systems in the display of 
sexual behaviors. This inhibition may be a result of increased circulating T, or increased 
bioavailability of E2, by T binding SHBG releasing E2 into the bloodstream, or 
conversion of T to E2. 
There was large variance in behaviors within the groups. Replication of this study 
with a larger group size, decreased variability in responses by using animals at a fixed 
age (versus a range of 2 months), and co-varying data by blood hormone levels should 
help in determining whether or not there is an actual effect of differing hormone regimens 
on the sexual behavior of aged animals. In addition, the dosage of hormones may have 
not have been optimal. Therefore, these data should be followed-up with a dose-response 
study. 
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An additional source of variance may be due to the males' reaction to the female. 
Although males were trained prior to the start of the experiment, they were trained with 
hormonally primed females who were showing normal levels of appetitive and 
consummatory behaviors. Perhaps the males were responding well to hormonally primed 
females, and were less inclined to attempt a copulatory bout with an older female who 
was possibly releasing less pheromonal cues and possibly less attractive, resulting in 
larger variance. Examining Fos activation in the male rats, when exposed to all but 
tactile cues could test this hypothesis. The design of such an experiment would place a 
young female in behavioral Estrus and an aged animal with Estrus cell morphology 
behind a screen. Male rats typically will show increased Fos activation in brain areas 
such as the NAcc, in response to estrous odors (Kippin, Cain, Pfaus, 2003). If it is the 
case that the aged animals are less attractive to the male due to one of these cues, then 
lower Fos counts would be expected in the animals exposed to the aged female, versus 
the young female in Estrus. Similarly, we would expect more DA to be released in males 
in areas such as the mPOA (Hull et al.,1995), when presented with a fully-primed (EB+P) 
OVX female versus the aged female, given the hypothesis that the OVX female is a more 
attractive sexual stimulus to the male compared to the aged female, so the males may be 
more sexually motivated to copulate with the OVX female. 
In summary, acute EB in aged animals facilitates sexual behaviors, particularly 
receptive behaviors (i.e. LQ). Neither the addition of P nor TP had a significant effect on 
either consummatory or appetitive behaviors. Whereas the chronic administration of both 
TP-alone or in combination with EB lead to an eventual attenuation of female sexual 
behaviors. 
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Experiment 3: Aged Intact Constant TP 
Introduction 
The results from Experiment 2 Phase 1 suggest that the 200 ug dose of TP may 
have been insufficient in the intact animals to see an acute effect, or that the hormonal 
state of the intact females was leading to large variance within groups to find differences 
between groups. In addition, chronic phasic administration of 200 ug TP via 
subcutaneous injection every 4 days did not facilitate sexual behavior, but in fact 
attenuated both consummatory (e.g. LQ) and appetitive behaviors over time. 
Transdermal administration of T in menopausal women has been shown to 
minimize unpleasant side effects that are often reported with oral doses and is thus the 
preferred route of administration. This method of administration has been successful in 
the treatment of sexual dysfunction in Europe. Sommerville and Tartellin (1983) have 
shown that in rats, subcutaneous silastic capsules are effective for administering 
prolonged hormone treatments, and that the rate of diffusion is proportional to the 
capsules' surface area. 
Experiment 3 consisted of 2 phases which investigated the effect of constant 
levels of TP administered subcutaneously via silastic capsules of varying sizes on the 





Forty retired breeder female rats of the Wistar strain were received from Charles 
River Canada (St. Constant, Quebec, Canada). Females were aged approximately 3-4 
months. All animals had bore at least one litter, however the supplier did not provide 
litter counts and sizes. Animal's general health was monitored through examination of 
behavior, teeth, nails and body weight. One animal died prior to the beginning of the 
experiment due to unknown reasons. 
Cell cytology. 
Beginning at approximately 8-9 months of age, vaginal cell cytology was collected 
in a similar manner to Experiment 2. Cell collection was continued daily during the first 
quarter of the dark cycle, until the end of the experiment. 
Hormonal procedures. 
Silastic capsules were made by cutting silastic tubing (Dow Corning Corporation, 
Midland, MI, USA; ID: 0.058, OD: 0.077) to varying lengths (5 mm, 10 mm) and filled 
with crystalline TP (Steraloids, Newport, RI) before being sealed with silicone glue. All 
capsules were incubated overnight in phosphate-buffer saline at room temperature, to 
release the initial burst of hormone (Mannino, South, Inturrisi, & Quinones-Jenab, 2005). 
Animals were separated into 4 groups receiving varying lengths of TP-filled silastic 
capsules: 5 mm (n=10), 10 mm (n=10), or two 10 mm (n=10) capsules. Control animals 
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(n=9) received a blank 5 mm capsule. All capsules were inserted following a baseline 
sexual behavior session. 
Experimental procedure. 
Animals were always tested during the middle-third of their dark cycle. Females 
received a baseline session and 10 sexual behavior tests, each separated by 4-day 
intervals, in bi-level chambers with vasectomized, sexually experienced males. All 
experimental tests were conducted with the implanted silastic capsule of TP. 
Behavioral analyses 
All behaviors that were observed in Experiments 1 and 2 were also analyzed in 
Experiment 3. 
Statistical analyses 
A one-way between-subjects ANOVA was run on each behavior to compare 
groups at baseline, and trial 1 (Tl) and trial 5 (T5) of both TP-alone and EB+TP tests. 
Repeated-measures ANOVAs were not used because the hormonal state of the animals 
varied from test to test, implying that the animal was actually very different from one test 
to the next, consequently, a between-subjects analysis was deemed more appropriate. 
Phase 1: Chronic administration of varying doses ofTP 
Results 
At baseline, there were no differences between any of the groups on any 
behavioral measure, M ± SEM are presented in Table 1. 
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Blank (n=7) 5mm(n=9) 10 mm (n= 10) 20 mm (n= 10) 
Behavior 
Appetitive 26.71*14.03 35.00*13.35 21.20*10.40 10.00±6.56 .43 
Level Change 15.43±5.34 14.11*2.98 18.40*6.98 14.60*5.32 .94 
Defenses 9.71*5.01 5.00*1.99 13.90*5.01 25.10*9.86 .17 
LM 1 1.14*0.55 4.56*3.64 1.50*1.08 0.20*0.13 .42 
LM2 5.14*2.38 6.22*3.67 5.30*4.13 0.10*0.10 .47 
LM3 21.29*11.34 15.00*6.09 6.40*3.20 7.30*4,88 .34 
LQ 0.46*0.17 0.53*0.15 0.30*0.12 0.20*0.11 .31 
Mount 29.00*11.11 26.44*10.27 17.9*4.86 13.60*2.71 .44 
Intromission 8.29*3.77 3.44*1.25 3.80*1.88 3.90*2.54 .51 
Ejaculation 1.14*0.63 0.22*0.22 0.60*0.34 0.60*0.43 .53 
Table 1. Sexual behaviors of intact aged female rats at baseline, prior to insertion of 
silastic capsules of TP. No differences were found between any of the groups on any 
behavior. 
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Figures of the behaviors of TP-alone at the specified trials are summarized in 
Figures 15 (male sexual behaviors towards female), Figure 16 (appetitive female sexual 
behaviors) and Figure 17 (consummatory female sexual behaviors). Behaviors at both 
time periods are presented for comparison purposes. 
Male behaviors. 
There was a significant effect of TP-alone on mounts at Tl, F(3,32)= 4.238, 
p=.012. Control animals received fewer mounts (1.14 ± .404) than the 20 mm group (34.4 
± 5.94) 
There was a significant effect of TP-alone on intromissions at Tl, F(3,32)=3.857, 
p=.018. Control animals received significantly fewer intromissions (0 ± 0) than the 20 
mm group (9 ± 1.6). 
Female appetitive behaviors. 
When hops, darts and solicitations were grouped into one measure of total 
appetitive behaviors, there was a significant effect of TP-alone at Tl, F(3,32)=3.404, 
p=.029. Controls displayed significantly fewer appetitive behaviors (2.86 ± 2.5) 
compared to the 20 mm group (47.1 ± 11.5). 
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Figure 15. Frequency of male sexual behaviors towards aged female rats following 
chronic administration of TP via subcutaneous silastic capsules over 5 test trials. Trial 1 
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Figure 16. Frequency of defensive and appetitive sexual behaviors of aged female rats 
following chronic administration of TP via subcutaneous silastic capsules over 5 test 
trials. Trial 1 (Tl) and Trial 5 (T5). * p<.05. 
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Figure 17. Frequency of consummately sexual behaviors of aged female rats following 
chronic administration of TP via subcutaneous silastic capsules over 5 test trials. Trial 1 
(Tl) and Trial 5 (T5) significant behaviors are displayed. * p<.05; # p >.05 <.10. 
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Female consummatory behaviors. 
There was a significant main effect of TP-alone on LM 1 at Tl, F(3,32)= 3.793, 
p<.05. Control animals displayed fewer LM Is (0.00 ± 0.00) compared to the 20 mm 
group (6.6 ± 1.8). 
There was a significant main effect of TP-alone on LM 2 at Tl, F(3,32)= 5.953, 
p<.002. The 20 mm group displayed significantly more LM 2 (16.3 ± 4.5) compared to 
controls (0.00 ± 0.00) or 10 mm (3.9 ± 1.7) animals. 
There was a significant effect of TP-alone on LQ at Tl, F(3,27)=6.011, p=.003. 
Controls had a significantly lower LQs (0.20 ± 0.20) than the 5 mm (0.71 ±0.12), 10 mm 
(0.90 ± 0.04), or 20 mm (0.80 ± 0.09) groups. 
Phase 2: Chronic administration of varying doses ofTP in combination with EB 
Hormonal procedures 
The day following the 5th sexual behavior test of TP-alone, capsules were 
removed and new ones were inserted (prepared and inserted as previously described). 
The control group (blank capsules) however, did not undergo any surgery on the second 
implant day, to reduce the risk of death or infection due to surgery. 
Forty-eight hours prior to each test session, animals were administered 10 ug of EB 
dissolved in 0.1 mL sesame oil via s.c. injection. 
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Results 
Figures of the behaviors of EB+TP at the specified trials are summarized in 
Figure 18 (male sexual behaviors towards female), Figure 19 (appetitive female sexual 
behaviors) and Figure 20 (consummatory female sexual behaviors). Behaviors at both 
time periods are presented for comparison purposes. 
Male behaviors. 
There was a significant effect of EB+TP on intromissions at Tl F(3,28)=5.27, 
p=.005. Control animals received significantly more intromissions than the 20 mm group. 
There was a significant effect of EB+TP on ejaculations at Tl, F(3,28)= 3.228, 
p=.037. Control animals received significantly more ejaculations than the 20 mm group. 
Female appetitive behaviors. 
There was a significant main effect of EB+TP on level changes at T5, 
F(3,32)=4.421, p=.010. The 5 mm group displayed more level changes than the control 
and 20 mm groups. 
There was a significant effect of EB+TP on total appetitive behaviors at Tl, 
F(3,28)=3.584, p=.026. Controls displayed significantly more appetitive behaviors 
compared to 20 mm. 
Female consummatory behaviors. 
There was a significant main effect for EB+TP at Tl F(3,28)= 5.386, p=.005, 
where control animals displayed significantly more LM 2s compared to the 5 mm, 10 
mm, or 20 mm groups. 
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Figure 18. Frequency of male sexual behaviors towards aged female rats treated with 
chronic TP via subcutaneous silastic capsules over 5 trials, when administered EB 48 
hours prior to testing (EB+TP). Test 1 (Tl) is represented on the left and Test 5 (T5) is 
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Figure 19. Frequency of appetitive and defensive behaviors of aged female rats following 
chronic administration of TP via s.c. silastic capsules over 5 trials, when treated with EB 
48 hours prior to testing (EB+TP). Test 1 (Tl) is represented on the left and Test 5 (T5) is 
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Figure 20. Frequency of consummatory sexual behaviors of aged female rats following 
chronic administration of TP via subcutaneous silastic capsules over 5 trials, when treated 
with EB 48 hours prior to testing (EB+TP). Test 1 (Tl) is represented on the left and Test 
5 (T5) is represented on the right; * p<.05. 
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There was a significant main effect of EB+TP on LM 3s at Tl, F(3,28)= 4.357, 
p=0.012. Control animals displayed significantly more LM 3s than the 10 mm or 20 mm 
groups. 
There was a significant effect of EB+TP on LQs at Tl, F(3,25)=4.022, p=.018. 
There was a dose-dependent decrease in LQ, where control animals displayed 
significantly more LQs than the 5 mm, 10 mm, or 20 mm groups. 
There was also a significant effect of EB+TP on LQs at T5, F(3,31)=3.218, 
p=.036. Here, there was also a dose-dependent decrease in LQ, where control animals 
had a significantly higher LQ than the 5 mm, 10 mm, or 20 mm groups. 
Discussion 
In Experiment 3 aged female rats were chronically exposed to varying doses of TP 
via subcutaneous capsules, either alone, or in combination with EB. When TP was 
administered alone, males initially responded with increased mounts and intromissions 
and females displayed more lordosis reflexes compared to control animals, in a dose-
dependent manner. Over time, however, the differences between groups were generally 
lost where animals receiving TP showed behaviors similar to control animals. 
When EB was administered 48 hours prior to the test, there was a dose-dependent 
decrease in all aspects of sexual behaviors that were observed, and this effect remained 
relatively stable over time. In this experiment, control animals were exposed to EB-alone. 
Thus, comparing control animals at Tl and T5 shows that chronic EB maintains a stable 
level of sexual behaviors. This suggests that when EB is administered with TP, there are 
changes affecting release of pheromonal cues (less mounts, intromissions and 
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ejaculations from the male), as well as activation of negative feedback onto the 
hypothalamus, inhibiting sexual behaviors, since LQs and appetitive behaviors were also 
dose-dependently decreased. This inhibition may be the result of increased levels of E2 
into the CNS by T binding SHBG, allowing more bioavailable E2 into the bloodstream, 
and via aromatization of T to E2. In this scenario, bioavailable E2 would increase as a 
function of TP dose. Increased E2 could, therefore, lead to the inhibition of sexual 
behaviors in aged females. 
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General Discussion 
The role of T in female sexual function and behavior has become more and more 
prominent in the literature, particularly with respect to its effects on sexual desire. 
Although there are reports in the literature pertaining to the effects of T on female sexual 
function in the OVX rat, few have been conducted in contexts that favor the full display 
of female sexual behavior. The present experiments studied the effect of TP, either alone 
or in combination with EB, on the sexual behavior of both young OVX and aged intact 
female rats. These experiments were run in bi-level chambers, to allow the full 
expression of female sexual behaviors (Pfaus, Smith, Coopersmith, 1999). 
The results from Experiment 1 Phase 1 showed that TP alone had no effect on 
any aspect of female sexual behavior in young OVX rats. When females were treated 
with EB, they displayed both appetitive and consummatory behaviors, however the 
addition of TP did not further affect sexual behaviors at any dose {Phase 2). Phase 3 
investigated varying hormone treatments on the sexual behavior or these same rats. The 
results showed that when animals were administered EB+TP, their combined effect was 
greater than the control groups receiving either oil or TP alone, and the effect was similar 
in magnitude to EB+P, particularly with respect to appetitive behaviors. 
Experiment 2 Phase 1 found that none of the tested hormone treatments, when 
administered acutely, had any effect on the sexual behavior of aged intact female rats. 
However, chronic subcutaneous injections of TP, either alone or in combination with EB, 
resulted in a progressive decline in sexual behaviors over time (Experiment 2, Phase 2). 
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Experiment 3 showed that initially, the steady release of TP via subcutaneous 
capsules, dose-dependently served to facilitate all aspects of sexual behaviors in aged 
females, however over time the effect was dose-dependently reversed. When animals 
were administered EB 48 hours prior to the test, there was a dose-dependent decrease in 
all aspects of sexual behavior initially, which was generally maintained over time. This 
suggests that steady levels of exogenous TP initially serve to facilitate sexual behaviors 
in aged female rats, but this effect is reversed with EB priming and with chronic TP 
administration. A viable explanation is that TP increases bioavailable E2 in the blood 
stream to exert negative feedback on the hypothalamus, inhibiting sexual behaviors in 
aged animals. In both Experiments 2 and 3, a decline in sexual behaviors occurred over 
time, suggesting that chronic administration of EB and TP activate negative feedback 
pathways that inhibit female sexual behavior. 
Effects of TP on sexual behaviors of young OVX females 
The results of Experiment 1 suggest that acute TP alone, when administered 4 
hours prior to the test, has no effect on female sexual behavior. However, when TP was 
administered with a prior injection of EB, this combined treatment did not increase sexual 
behaviors to any degree greater than treatment with EB alone. In addition, when 
comparing varying hormone treatments, the combined effect of EB+TP increased 
appetitive and consummatory behaviors similar in a treatment of EB+P and greater than 
EB-alone, though this latter effect was not significant. 
The fact that the oil and TP-alone groups displayed low levels of sexual behaviors 
in Phase 3, suggests that carry-over effects from EB and/or TP from Phase 2 and 
possibly TP doses from Phase 1 may have masked the effects. Consequently, this study 
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should be replicated with proper controls. An important factor contributing to these 
results is that the doses of EB and P used in these experiments are based on studies used 
in the literature to study female sexual behavior when they are showing maximal levels of 
receptivity. The EB dose, in particular, is supraphysiological and the behavioral effects 
are not necessarily representative of the levels that would be observed in intact females in 
behavioral Estrus. The high levels of hormones may also be resulting in ceiling effects, 
obscuring the effects of varying hormone treatments of TP when given in combination 
with EB. Consequently, future studies should ensure that the behavioral baseline is low, 
perhaps by decreasing the EB dose or allowing a sufficient time lapse between 
experiments. The proper dosing regimen and schedule to prevent a high baseline, is not 
yet known. 
The addition of P to an EB-treated female typically results in a significant increase 
in sexual behaviors (Pfaus, Smith, Coopersmith, 1999; Whalen, 1974). Experiment 1, 
Phase 3 did not find any significant differences between these groups, which may be due 
to carry-over effects of TP and/or EB from Phases 1 and 2 of the same experiment. 
Consequently, this experiment should be replicated with a washout period to prevent 
carry-over effects. The duration of this washout period however, is not known, thus it 
would first be important to sequentially test EB over varying time intervals (e.g. 4, 8, 12, 
16 days). Furthermore, the EB dose used in these experiments (10 ug) are 
supraphysiological and consequently, varying doses of EB (e.g. 0, 2.5, 5, 10 ug) should 
also be tested over varying time intervals, where an ideal dosing regimen would induce 
consistent levels of sexual behaviors at four day intervals, mimicking the estrous cycle. 
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Optimal levels of estrogen facilitate sexual behaviors in aged animals 
When administered acutely to aged animals, EB significantly increased LQ 
(Experiment 2). The administration of TP-alone had no effect on sexual behaviors, and 
when administered in combination with EB, did not add to EB's effect. When EB or 
EB+TP were administered chronically, no initial effects on sexual behavior were 
observed, however, these behaviors decreased over time (Experiment 2 Phase 2). In 
contrast, when TP was administered alone via subcutaneous capsules, releasing steady 
levels of TP (Experiment 3 Phase 1), sexual behaviors were at first facilitated in aged 
animals but then attenuated over time. A similar reduction in sexual behaviors occurred 
when moderate or high doses of TP were added to the EB regimen in Experiment 3 Phase 
2. These results suggest that low levels of EB in aged animals due to decreased ovarian 
steroid production blunt the expression of sexual behavior and the addition of exogenous 
EB facilitates sexual behavior in those animals, but only when administered at an optimal 
dose. However, when EB reaches high levels (increasing bioavailable E2 by either the 
chronic administration of 10 mm and 20 mm TP capsules [TP-alone on T5] or when these 
TP doses are added to an EB regimen [EB+TP on Tl and EB+TP on T5]) sexual 
behaviors are dose-dependently attenuated. This relationship is depicted in Figure 21, 
where varying bioavailable E2 levels lead to an inverted U-shaped curve with respect to 
sexual behaviors in aged animals, such that low and high bioavailable E2 levels prevent 
the expression of sexual behaviors, whereas moderate levels facilitate them. 
Dow, Hart and Forrest (1983) reported no differences in the improvement of 
sexual symptoms between postmenopausal women treated with E2 or EB+T. However, 
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Figure 21. Proposed effect of bioavailable estrogen levels on sexual behavior in aged 
female rats. Low levels of estrogen (i.e. due to a decline in ovarian steroid hormone 
production with age) as well as high levels of E (secondary to chronic administration of 
TP, or the addition of TP to an EB-regimen) attenuate sexual behaviors. Moderate levels 
of EB (by the steady release of TP administered alone via subcutaneous capsules in the 
short-term, or by subcutaneous administration of EB-alone) serve to facilitate sexual 
behaviors in aged animals. 
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criteria of the subjects, and subsequently showed that a factor determining the successful 
treatment effect of E2+T pertains to prior treatment with E2. The authors selected women 
who had reported low libido despite an E2 and P hormone regimen. Subjects were 
randomly assigned to either an E2-alone regimen or an E2+T regimen. Libido and sexual 
enjoyment self-report scores were measured prior to treatment and every 6 weeks 
following treatment. Women in the E2+T group reported significant improvement on 
both libido and sexual enjoyment scales, whereas those in the E2-alone group did not 
show any improvement. In addition, when T was added to the E2-alone group, the self-
reports 6 weeks later showed a significant improvement on both libido and sexual 
enjoyment scales. The authors conclude that E2+T may be effective for a sub-group of 
women who are unresponsive to E. Interestingly, the effect was maintained for up to 18 
weeks, however at week 24, both reports of libido and sexual enjoyment returned to 
baseline levels. The eventual attenuation of sexual behavior in aged animals treated 
chronically with TP or EB+TP (Experiment 2 Phase 2) or high doses of steady levels of 
TP (Experiment 3 Phase 1) parallels well with the study reported by Burger et al. (1987), 
which suggests similar underlying inhibitory mechanisms of hormone actions on sexual 
behavior in the female human and rat. 
Korenchevsky and Dennison (1937) found that in OVX female rats, chronic TP 
administration (21 days), both alone and in combination with E2, led to increased uterine 
weight, and hypertrophy of the vagina and clitoris. The results of the chronic experiments 
presented in this thesis, would suggest that regrowth of reproductive tissue does not 
translate into improved sexual responding. This is similar to the actions of sildenafil 
citrate (Viagra) which increases blood flow to reproductive tissues in women, but does 
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not ameliorate disorders of sexual arousal or desire (Basson, Mclnnes, Smith, Hodgson & 
Koppiker, 2002; Laan, van Lunsen, Everaerd, Riley, Scott & Boolell, 2002). Therefore, 
restoring reproductive tissue in both women and female rats does not imply restoration of 
reproductive behaviors. This further reinforces the idea of a "disconnect" between 
central and peripheral aspects of sexual function in females. 
E+T in the treatment of HSDD in menopausal women 
Work in humans has provided strong evidence to suggest that reduced levels of T 
are important in the disruption of certain psychological aspects in women, including 
those with reduced androgen levels caused by ovarian, adrenal, hypothalamic, drug-
related or idiopathic factors (Bachmann et al., 2002; Braunstein, 2002). Testosterone in 
menopausal women has been shown to increase positive feelings of well-being, energy 
and libido, symptoms that are not restored with ERT alone (Burger, Hailles, Menelaus 
, Nelson, Hudson & Balasz, 1984; Burger, Hailes, Nelson & Menelaus, 1987; Davis, 
McCloud & Sherwin, 2002; Sherwin & Gelfand, 1987; Davis, McCloud, Strauss & 
Burger, 1995). Although some studies have found no correlation between androgen levels 
and increased libido (Dennerstein, Dudley, Hopper, & Burger, 1977), many clinical 
studies have reported significant increases in sexual functioning in particular with regard 
to the psychological aspects such as desire, sexual fantasies, and sexual reward or 
enjoyment (e.g. Burger et al., 1995; Burger et al., 1997; Sherwin & Gelfand 1985). 
Europe and Australia have an approved transdermal T patch as a treatment of 
libido disorder for women receiving ERT. The US FDA reviewed the transdermal patch 
and its approval was rejected (FDA Inrinsa Advisory Committee Background Document 
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Overview, 2004). The addition of T to ERT in naturally and surgically menopausal 
women is controversial, namely because the long-term effects are not well known, and 
because little is known regarding the mechanism of action of androgens on female sexual 
function. 
The results from Experiments 2 and 3, examining chronic administration of TP 
suggest that long-term treatment of TP diminishes the initial increase in sexual desire, at 
least in aged animal. This is preliminary evidence that long-term use of E-A regimens 
attenuates the initial beneficial effect on libido, and suggests that treatment may require 
"on" and "off periods to thwart or delay the reduced effectiveness. 
Localization of E-A mechanisms 
Subcutaneous administration of E+T has profound effects on sexual function. 
Some of these effects are peripheral, while others are central. The present experiments 
investigate downstream central effects on sexual behavior. But where in the central 
nervous system are these effects taking place? Some of the most obvious areas to begin 
looking would be the substructures of the hypothalamus, particularly the SCN, since it is 
involved in the control of circadian rhythms (estrous cycles), and the mPOA and VMN 
which are critical in the control of sexual behaviors; as well as brain areas involved in 
motivated and rewarding behaviors such as the VTA and NAcc. 
Suprachiasmatic nucleus of the hypothalamus. 
Ovarian transplants of aged acyclic females into young females cause young 
animals to begin cycling again, whereas young ovaries into aged females does not 
(Aschheim, 1961; Felicio, Nelson, & Finch, 1986; Peng & Huang, 1972), suggesting that 
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the brain plays a major role in reproductive aging and acyclicity. Lesions to the SCN 
have been shown to disrupt ovarian cyclicity, and light-induced Fos expression in the 
SCN is attenuated and delayed in middle-aged females, but can be restored to levels 
equivalent to young animals following transplantation of fetal SCN tissue into the third 
ventricle (Cai, Lehman, Lloyd & Wise, 1997). The SCN is involved in the cyclicity of the 
estrus cycle and lesions to the SCN result in persistent estrus (Wiegand & Terasawa, 
1982). The SCN presumably does not have steroid hormone input, supported by 
autoradiography studies finding no ER in the SCN (Pfaff, 1980). However, the SCN has 
projections to GnRH neurons and neurons involved in the LH surge (Watson, Langub, 
Engle & Maley, 1995). Consequently, although it may have downstream actions in the 
control, cessation and reinstatement of sexual behaviors, it is unlikely that E and T are 
having direct effects on this structure. 
Medial preoptic and ventromedial hypothalamus. 
Other areas of the hypothalamus such as the mPOA and VMH, however, are critical 
for female sexual behaviors. Estrogen and androgen receptors are located in these areas, 
where E2 and P act in the VMH to induce lordosis in females, and P is known to act in 
the mPOA to facilitate appetitive behaviors, in particular, solicitations. Estrogens and 
androgens also act in the mPOA of males to restore copulatory behaviors. 
Progesterone binding to its receptor first activates sexual behaviors but additional 
P binding results in deactivation of the receptor, terminating sexual receptivity 
(McCarthy and Becker, 2002; Reading, Blaustein, 1984). In OVX middle-aged female 
rats, E2 nuclear receptor and P cytosol receptor densities have been shown to be 
significantly lower in the POA and medial basal hypothalamus after 2 days of E2 
74 
exposure compared to young OVX rats. This difference was alleviated on day 4 of E2 
exposure, suggesting that middle-aged rats require greater or longer exposure to E2 for 
protein synthesis of P receptors (Wise and Parsons, 1984). When comparing nuclear E 
binding in the POA of middle-aged rats versus young females, it was found that 
decreased nuclear ER binding was correlated with increased ER in the cytosol, 
suggesting that the interaction between the ER complex and the nucleus is what is 
disrupted in aged females and not the receptors themselves (Rubin, Fox, Bridges, 1986). 
This may explain both the results of EB+P treated intact females in Experiment 2 Phase 
1, as well as the results of Chambers and Phoenix (1986) who found that EB+P restored 
lordosis, but only low levels of appetitive behaviors in OVX aged animals. Aging 
animals may require longer exposure or higher doses of EB for protein synthetic effects 
to occur. For instance, if P receptors were not yet synthesized, the administration of P 
would result in only a low level of P-mediated appetitive sexual behaviors. 
The VMH and mPOA are important regions for E2-induced consummatory sexual 
behaviors (Pfaff, 1980), where lesions of these areas reduce or abolish the expression of 
lordosis. (Whitney, 1986; Yang & Clemens, 2000). Administration of crystalline E2 into 
these brain areas facilitates sexual behaviors (Pfaff, 1980). Androgens have been shown 
to be important in non-human primates with respect to appetitive behaviors, which were 
increased in OVX rhesus monkeys following TP administration into the POA (Everitt &" 
Herbert, 1975). 
It has been shown that cystolic androgen receptors are present in many brain areas 
involved in sexual behavior, including the mPOA and VMH, in both males and females, 
although the density is higher in males than in females (McGinnis & Katz, 1996). This 
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raises the possibility that androgens may contribute to the acute effect of facilitation of 
sexual behaviors in EB+TP primed animals, through androgen receptors in the mPOA. 
It is known that E2 potentiates lordosis behaviors through actions in the VMH, and 
P further facilitates appetitive behaviors by acting on the mPOA (Blaustein & Erskine, 
2002; Pfaff, Schwartz-Giblin, McCarthy & Kow, 1994; Blaustein & Mani, 2007). 
Because T restored appetitive behaviors equivalent to EB+P in OVX rats, and because 
androgen receptors are present in the mPOA, it is reasonable to hypothesize that T may 
be acting on androgen receptors in the mPOA to restore sexual behaviors in young OVX 
females. If this were true, then perhaps androgen receptor densities or binding is 
attenuated or delayed in the aged female brain given that the effect of EB+TP in these 
animals was no different from EB-alone (Experiment 1). Future studies could use 
autoradiography to compare androgen receptor binding in hypothalamic regions such as 
the mPOA and VMH at varying time periods in both aged intact and OVX rats given 
hormone replacement. 
Alternatively, given that crystalline E2 administered directly into the VMH and 
mPOA facilitates sexual behaviors (Pfaff, 1980), the aromatization of T to E2 in these 
brain areas may also explain the facilitation of sexual behaviors in these animals. Co-
administering T and aromatase inhibitors directly into the brain would test this 
hypothesis. If aromatase inhibitors prevented an increase in sexual behaviors, it could be 
suggested that E2 is responsible for the effect. 
It is known that the LH surge is attenuated and delayed in middle-aged rats 
(Cooper, Conn & Walker, 1980), that it can be restored in OVX middle-aged rats with 
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physiological levels of E, but that this restoration necessitates longer exposure to E2 
compared to young OVX rats (Wise & Parsons, 1984). Also, as previously discussed, 
synthesis of P receptors requires greater or longer exposure to E2 in middle-aged OVX 
females compared to young OVX animals (Wise & Parsons, 1984). To test whether 
receptor synthesis or binding is delayed in aged animals, future experiments can study the 
effects of TP and P following a longer exposure to E2, which should facilitate sexual 
behaviors to greater degree than E2-alone if receptor synthesis is delayed in these 
animals. 
Testosterone has been shown to act directly on the androgen receptor to affect 
female reproductive tissue (Traish et al., 2002; Traish et al., 2007) as well as to affect 
motivational aspects of sexual behavior in primates following TP implants to the AH and 
mPOA (Everitt & Herbert, 1975). Cystolic androgen receptors are present in many brain 
areas involved in sexual behavior (McGinnis & Katz, 1996) including the mPOA and 
VMH. The results of the TP-alone dose response study in young OVX females suggest 
that T may be acting synergistically with EB and directly acting on androgen receptors to 
restore sexual behavior. In experiment 1 Phase 1, young OVX females were administered 
varying doses of TP, including the highest dose of 400 ug. If aromatization was 
responsible for the restoration of sexual behaviors, the animals receiving the highest dose 
should have displayed some level of sexual behaviors, which was not the case. This lends 
support to the hypothesis that TP must be interacting with EB in some way, in order to 
facilitate sexual behaviors. Androgen receptor blockers such as flutamide, administered 
with EB+TP treatment would test whether or not T is binding its receptor to activate 
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sexual behaviors. If the effect were to be blocked following flutamide administration, the 
results would support direct actions of T on its receptor. 
Mesolimbic dopamine system. 
The mesolimbic DA system projects from the VTA to limbic structures such as 
the NAcc, amygdala, and septum, and is involved in motivation and attention to reward-
related stimuli. Progesterone in the VTA has been shown to be important for the 
induction of lordosis behaviors via binding to GABAa receptors or interacting with 
second-messenger systems activated by dopamine binding to the DA receptor 1 subtype 
(Frye, 2001; Frye and Waif, 2008). Estrogen binding in the NAcc and striatum decreases 
inhibitory actions of GAB A or DA autoreceptors, promoting DA release (Becker, 1999). 
Dopamine in the NAcc increases in female rats when the context is rewarding for the 
female, e.g., when copulation occurs at the females' preferred intervals (Becker, Rudick 
& Jenkins, 2001). These mechanisms of steroid hormone actions in aged females are 
likely to be involved in the disruption of sexual behavior as well as the restoration of 
sexual behaviors in both OVX and aged animals treated with EB+TP. 
Mechanism of estrogen/androgen treatment 
Estrogenic actions. 
The effect of EB+TP observed in the present experiments may due to an 
estrogenic effect, through the aromatization of T to E2, or T binding to SHBGs displacing 
E2 which releases more of it into the blood stream to elicit its effects, as proposed by 
Wallen (2001). Both EB and EB+TP elicited a similar effect on lordosis in the aged intact 
animals receiving acute administration, suggesting that TP does not add to EB's effect. 
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Similarly, in the young OVX animals, EB+TP treated animals displayed more appetitive 
behaviors, which may have occurred due to increased levels of bioavailable E2 into the 
hypothalamus (possibly the mPOA or VMH) to further facilitate sexual behavior. This 
idea can be tested by the addition of a group of OVX animals receiving EB 48 hours 
before, followed by EB 4 hours prior to testing, and comparing this effect to EB+TP 
animals. If the effect is due to increased circulating E2, then administering additional EB 
4 hours prior to the test should result in sexual behaviors equivalent to EB+TP. 
In aged animals, although TP-alone via subcutaneous capsules facilitates the 
induction of sexual behaviors, chronic TP-alone eventually leads to a reduction in these 
behaviors, and EB+TP reduces sexual behaviors as of the first test trial. It seems probable 
therefore, that TP is either being aromatized, or binding SHBG, ultimately increasing 
bioavailable E2, activating negative feedback in the CNS and attenuating sexual 
behaviors. Replicating this study but with the addition of an aromatase inhibitor, 
androgen receptor blocker, or administering E2 directly into the brain (e.g., to mPOA or 
VMH), may help to determine whether this hypothesis is tenable. If the effect is not 
apparent following aromatase inhibition then it can be assumed that E2 is responsible for 
the inhibitory effect of sexual behaviors following long-term use. This can be further 
supported with E2 infusions into areas such as the VMH or mPOA, which should yield 
similar results. 
An additional hypothesis to explain the acute effects observed in the aged females 
is the possibility that the female brain may become masculinized as hormonal cyclicity is 
disrupted, such that E2 cells in the hypothalamus become dormant, until moderate 
amounts of E2 activate them. It may also be that aged cycling females synthesize higher 
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concentrations of aromatase in the CNS, which would explain the facilitatory effect of 
subcutaneous capsules of TP-alone in increasing sexual behaviors. To test this, aromatase 
activity in the hypothalamic structures involved in sexual behavior can be measured in 
young receptive, middle-aged and old-aged females, with the hypothesis that aromatase 
concentration increases with age. 
Summary of mechanisms. 
Estrogen and T, when administered together, restore sexual behavior in OVX 
female rats, similar to the actions of EB+P, which should typically restore all aspects of 
sexual behavior including appetitive and consummately behaviors. Testosterone may be 
directly involved in the induction of sexual behaviors in females, in particular with 
respect to appetitive behaviors in young OVX rats, as well as in aged animals exposed to 
a steady dose of TP through subcutaneous silastic capsules. The biological mechanisms 
involved in this effect are unclear, however the aromatization hypothesis, whether 
androgens lead to increased bioavailable E2 which would then elicit the effects, or 
whether what we are seeing is a direct effect of androgens on its receptor may be 
reasonable explanations, but the available evidence in the literature at this time, fails to 
support one clear hypothesis. The results of these experiments, however, raise the 
possibility that androgens may have facilitatory effects in young OVX females as well as 
in aged animals receiving constant TP, but that E2 activates negative feedback 
mechanisms, preventing long-term restoration of sexual behaviors, in older intact aged 
females, and possibly in young intact animals, though this experiment has not yet been 
conducted. 
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Overall, these studies suggest that E2 and perhaps other steroid hormone effects 
are attenuated and delayed in the aging female, necessitating longer exposure to elicit the 
desired effects. They also suggest a potential for the restoration of function provided 
adequate treatment is administered, since many of these negative effects (e.g., light-
induced Fos expression, delays in P receptor synthesis, decreases in sexual behaviors) can 




The present experiments have investigated varying doses of TP on the sexual 
behavior of young OVX and aged intact female rats. The results of these experiments 
have shown that TP-alone has no effect on the sexual behavior of young OVX female 
rats, and the administration of EB facilitates both appetitive and consummatory behaviors 
but the addition of TP does not affect EB's effect at any of the doses tested. When the 
effects of varying hormone regimens were compared, the administration of EB+TP 
reinstates sexual behaviors to levels equivalent to EB+P, however this was not 
significantly different from EB-alone treated animals, which suggestes carry-over effects 
due to the methodology. The aged female rat, when treated acutely by subcutaneous 
injection with either TP-alone or in combination with EB does not initially affect sexual 
behaviors, however over time the behaviors are reduced. The administration of TP at a 
constant dose through subcutaneous capsules, dose-dependently facilitates sexual 
behaviors, however chronically the effects are lost. Similarly, when EB is added to the 
TP regimen, sexual behaviors are dose-dependently decreased. The initial facilitation and 
subsequent attenuation of these behaviors following EB and TP treatment in aged animals 
enables the study of these hormone interactions both centrally and peripherally, in the 
aging brain. The experiments on chronic administration allude to the idea that the initially 
beneficial effects of these treatments are abolished following chronic HRT. 
The results of the present experiments prompt additional research questions 
regarding the underlying mechanisms of E-A interactions. The brain areas that are 
activated or deactivated, and neurotransmitter effects in these regions following these 
different treatments can be investigated with Fos immunocytochemistry and micro-
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dialysis respectively, allowing us to further understand how these hormone treatments 
differentially effect these brain areas. 
The receptors that are involved in the effects can be studied via androgen and E 
receptor blockers, and receptor subtypes in the case of ERs can be further explored by 
selectively blocking ERa or ERp\ Subsequent research in the mesolimbic DA system can 
explore how DA synthesis or release act to ameliorate symptoms initially, and what leads 
to the disruption chronically. It is hoped that the present experiments have opened the 
door to myriad questions that can now be addressed regarding the hormonal mechanisms 
associated with the decline of sexual function when ovarian function has been altered, 
and how it can be restored by exogenous hormone replacement therapy. 
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